Antag Therapeutics has announced the closing of an €80 million Series A financing round to develop AT-7687, a novel therapy targeting obesity. The round was led by Versant Ventures, with Novo Holdings ...

Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute ...

Orbit Discovery, based in Oxford, UK, and Evergreen Theragnostics, headquartered in Springfield, NJ, USA, have announced the ...

New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of its enhanced SureSeq CLL + CNV ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Cytomos has announced that it has raised $5m in an oversubscribed funding round to scale up production of its cell analysis ...

A precise and realistic TPP can define a clear path to market and commercial success by bridging the gap between research and ...

How industry and the NHS can work together to bridge the diagnostic gap in COPD Lord Darzi’s recent report on the state of ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles ...